JLL and Mainstreet Capital Partners Close Deal with Azzur Cleanrooms on Demand™

June 1, 2021, Raleigh, NC – JLL today announced that Azzur Cleanrooms on Demand™, a market-leading provider for early-phase life sciences GxP manufacturing, has signed a 75,000-square-foot lease at INQ 1101, a 140,000-square-foot creative office and lab building in the heart of the Research Triangle. This deal brings the facility to 100% leased. JLL’s John MacDonell represented the owner in the transaction and Newmark’s Doug Brock represented the tenant.

“We’re pleased to partner with Azzur Group to bring its ready-to-use cleanrooms to the Raleigh metropolitan area,” said Peter Tonon, partner at Mainstreet Capital Partners. “As the Triangle’s biotech scene continues to boom, biological cleanroom technology is in high demand. With Raleigh ranked among the nation’s top markets for innovation in technology and life sciences, INQ 1101 proved to be the ideal location for the concept’s first expansion into the region.”

Azzur Cleanrooms on Demand™ offers a hybrid, early-phase manufacturing model geared specifically toward the challenges faced by startups in the early lifecycle. Through Azzur’s local on-demand cleanrooms, advisory and consulting services, microbiology lab, and GxP training center, Raleigh-area innovators have access to customized solutions to accelerate their time to market and successfully scale up and out. Additional locations include Boston, Burlington, and San Diego. Additional locations are planned for major U.S. biotech hubs.

Located at 1101 Shiloh Glenn Drive, INQ 1101 is strategically positioned within the heart of Raleigh's Research Triangle. The facility is adjacent to the I-40/I-540 interchange and is less than five miles from Raleigh-Durham International Airport and Research Triangle Park. Additionally, INQ 1101 offers unrivaled access to more than 30 restaurants and hotels. In February, Schneider Electric USA signed a 65,000-square-foot lease at the building.

“The Triangle’s leading academic institutions and Raleigh’s burgeoning tech ecosystem position the region to become a true biotech hub, and we’re pleased to close this deal with a leading life sciences service provider to deliver much-needed manufacturing space to Raleigh’s biopharm innovators and startup community,” said JLL’s MacDonell.

INQ 1101 was acquired by Mainstreet Capital Partners and a fund managed by DRA Advisors LLC in the fall of 2019. The building was immediately renovated to accommodate creative office users and in the fall of 2020, the property was rezoned to accommodate lab and life sciences users.